Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)
ClinicalTrials.gov study NCT01211691. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00380653. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT00217646. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT00303472. IPD Sharing: Not stated. Countries: 0. Publications: 1.
FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00042822. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00020969. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00043134. IPD Sharing: Not stated. Countries: 10. Publications: 0.
Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Patients Undergoing All
ClinicalTrials.gov study NCT01746147. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Microtransplantation With Decitabine and Cytarabine Improves Patient Outcomes in Myelodysplastic Syndromes
ClinicalTrials.gov study NCT01674985. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders
ClinicalTrials.gov study NCT00186576. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of RO6870810/TEN-010 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02308761. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT01496495. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload
ClinicalTrials.gov study NCT00481143. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Head to Head Comparison of Azacitidine and Decitabine in Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01409070. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Role of Erythropoietin in Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00723112. IPD Sharing: Not stated. Countries: 1. Publications: 12.
3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00077558. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk
ClinicalTrials.gov study NCT02757989. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02212561. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML)
ClinicalTrials.gov study NCT02447666. IPD Sharing: Not stated. Countries: 13. Publications: 1.
A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients
ClinicalTrials.gov study NCT01613976. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.